Diarrhea-predominant Irritable Bowel Syndrome
📧 Sign up to get email alerts when something new happens for Diarrhea-predominant Irritable Bowel Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-12-17Clinical Trial Update: Study on the Effectiveness and Mechanism of Tong-Xie-Yao-Fang in Treating Diarrhea-predominant Irritable Bowel Syndrome [Phase 1]
Phase 1 clinical trial evaluating the effectiveness and mechanism of Tong-Xie-Yao-Fang in treating diarrhea-predominant irritable bowel synd…
-
CLINICAL_TRIALS trial_result · 2023-01-18Clinical Trial Update: Changyanning Tablet for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) [Phase 2, Phase 3]
A clinical trial update for Changyanning Tablet evaluating its use in diarrhea-predominant irritable bowel syndrome across Phase 2 and Phase…
-
CLINICAL_TRIALS trial_result · 2021-06-07Clinical Trial Update: Study to Evaluate the Efficacy, Safety, and Tolerability of BOS-589 in the Treatment of Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) [Phase 2]
Phase 2 clinical trial evaluating BOS-589 for diarrhea-predominant irritable bowel syndrome has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-01-08Clinical Trial Update: Rifamycin SV-MMX® 600 mg Tablets Administered Three or Two Times Daily to Patients With IBS-D [Phase 2]
Phase 2 trial update evaluating Rifamycin SV-MMX 600 mg tablets given two or three times daily in diarrhea-predominant irritable bowel syndr…
-
CLINICAL_TRIALS trial_result · 2016-02-08Clinical Trial Update: Effect of Ranolazine on Gastrointestinal Motor Function and Pain in Patients With IBS-D [Phase 2, Phase 3]
This clinical trial update reports results from Phase 2 and Phase 3 studies evaluating ranolazine for gastrointestinal motor function and pa…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-10-12Clinical Trial Update: A Long Term Study of YM060 in Female Patients With Diarrhea-predominant Irritable Bowel Syndrome [Phase 3]
Phase 3 long-term study of YM060 in female patients with diarrhea-predominant irritable bowel syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2014-02-05Clinical Trial Update: The Effect of Neu-P11 on Symptoms in Patients With D-IBS
A completed clinical trial evaluating the effect of Neu-P11 on symptoms in diarrhea-predominant irritable bowel syndrome.
-
CLINICAL_TRIALS trial_result · 2013-12-30Clinical Trial Update: Treatment of Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) With LACTEOL® 340 mg [Phase 3]
Phase 3 study evaluating LACTEOL 340 mg for diarrhea-predominant irritable bowel syndrome was terminated, with results posted on 2013-12-30.
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS) [Phase 3]
A Phase 3 trial evaluating asimadoline for diarrhea-predominant irritable bowel syndrome has completed.